Application 205626

Type
NDA
Sponsor
MICRO LABS

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001LAMIVUDINE, NEVIRAPINE AND ZIDOVUDINELAMIVUDINE; NEVIRAPINE; ZIDOVUDINETABLET;ORAL150MG;200MG;300MGYesNo

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N205626-001LAMIVUDINE, NEVIRAPINE AND ZIDOVUDINELAMIVUDINE; NEVIRAPINE; ZIDOVUDINE150MG;200MG;300MGTABLET / ORALRLD2018-08-13

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 2 of 2 · 45 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N205626-001LAMIVUDINE, NEVIRAPINE AND ZIDOVUDINE150MG;200MG;300MGTABLET / ORALRLD2018-08-133a93d1ddd44b…
2022-10-28 04:53 UTC2022-10N205626-001LAMIVUDINE, NEVIRAPINE AND ZIDOVUDINE150MG;200MG;300MGTABLET / ORALRLD2018-08-13f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09N205626-001LAMIVUDINE, NEVIRAPINE AND ZIDOVUDINE150MG;200MG;300MGTABLET / ORALRLD2018-08-13e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07N205626-001LAMIVUDINE, NEVIRAPINE AND ZIDOVUDINE150MG;200MG;300MGTABLET / ORALRLD2018-08-13cb3db0bc1861…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N205626-001LAMIVUDINE, NEVIRAPINE AND ZIDOVUDINE150MG;200MG;300MGTABLET / ORALRLD2018-08-13a50c72e98297…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 1 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
42571-166Lamivudine, Nevirapine, and ZidovudineLamivudine, Nevirapine, and ZidovudineMicro Labs LimitedNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
56557ORIG2018-11-26
55213ORIG2018-08-20
55179ORIG2018-08-15
55178ORIG2018-08-15
63009ORIG1900-01-01
63008ORIG1900-01-01
63007ORIG1900-01-01